Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Ulrik, Fahnøe"'
Autor:
Long V. Pham, Alexander P. Underwood, Alekxander Binderup, Ulrik Fahnøe, Carlota Fernandez-Antunez, Blanca Lopez-Mendez, Line Abildgaard Ryberg, Andrea Galli, Christina Sølund, Nina Weis, Santseharay Ramirez, Jens Bukh
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
The evolution of SARS-CoV-2 has led to the emergence of numerous variants of concern (VOCs), marked by changes in the viral spike glycoprotein, the primary target for neutralising antibody (nAb) responses. Emerging VOCs, particularly omicron sub-line
Externí odkaz:
https://doaj.org/article/a92a700b014849119526b7299e799525
Autor:
Anna Offersgaard, Carlos R. Duarte Hernandez, Yuyong Zhou, Zhe Duan, Karen Anbro Gammeltoft, Katrine T. Hartmann, Ulrik Fahnøe, Pavel Marichal-Gallardo, Garazi Peña Alzua, Alexander P. Underwood, Christina Sølund, Nina Weis, Jesper Hansen Bonde, Jan P. Christensen, Gabriel K. Pedersen, Henrik Elvang Jensen, Kenn Holmbeck, Jens Bukh, Judith Margarete Gottwein
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-18 (2024)
Abstract Rapidly waning immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires continued global access to affordable vaccines. Globally, inactivated SARS-CoV-2 vaccines have been widely used during the SARS-CoV-2 pande
Externí odkaz:
https://doaj.org/article/7364ae58a77642cc80f00f3bfff1ca99
Autor:
Ulrik Fahnøe, Lone Wulff Madsen, Peer Brehm Christensen, Christina Søhoel Sølund, Sarah Mollerup, Mette Pinholt, Nina Weis, Anne Øvrehus, Jens Bukh
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 9 (2024)
ABSTRACT Coinfections with human pegivirus 1 (HPgV-1) are common in chronic hepatitis C virus (HCV) patients. However, little is known about whether HPgV-1 is affected by direct-acting antivirals during HCV treatment. Metagenomic analysis and reverse
Externí odkaz:
https://doaj.org/article/65854ff025304af39a7f4d8aa882c8d7
Autor:
Alexander P. Underwood, Christina Sølund, Kivin Jacobsen, Alekxander Binderup, Carlota Fernandez-Antunez, Lotte S. Mikkelsen, Dilek Inekci, Signe Lysemose Villadsen, Jose A. S. Castruita, Mette Pinholt, Ulrik Fahnøe, Santseharay Ramirez, Liselotte Brix, Nina Weis, Jens Bukh
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
As severe acute respiratory coronavirus 2 (SARS-CoV-2) variants continue to emerge, it is important to characterize immune responses against variants which can inform on protection efficacies following booster vaccination. In this study, neutralizing
Externí odkaz:
https://doaj.org/article/f4f02d14888b456b8a2729d7250fc4fc
Autor:
Alexander P. Underwood, Christina Sølund, Carlota Fernandez-Antunez, Signe Lysemose Villadsen, Lotte S. Mikkelsen, Ulrik Fahnøe, Signe Bollerup, Anni Assing Winckelmann, Uffe Vest Schneider, Alekxander Binderup, Greta Vizgirda, Anna-Louise Sørensen, Caroline Nørløv Vinten, Magnus Illum Dalegaard, Santseharay Ramirez, Nina Weis, Jens Bukh
Publikováno v:
EBioMedicine, Vol 89, Iss , Pp 104475- (2023)
Summary: Background: Given the importance of vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the prevention of severe coronavirus disease 2019 (COVID-19), detailed long-term analyses of neutralising antibody respon
Externí odkaz:
https://doaj.org/article/f0bd2b415d514ce0b6ceeba2a996b746
Autor:
Anna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, Pavel Marichal-Gallardo, Kenn Holmbeck, Anne Finne Pihl, Carlota Fernandez-Antunez, Garazi Peña Alzua, Katrine Top Hartmann, Long V. Pham, Yuyong Zhou, Karen Anbro Gammeltoft, Ulrik Fahnøe, Uffe Vest Schneider, Gabriel Kristian Pedersen, Henrik Elvang Jensen, Jan Pravsgaard Christensen, Santseharay Ramirez, Jens Bukh, Judith Margarete Gottwein
Publikováno v:
iScience, Vol 26, Iss 2, Pp 105949- (2023)
Summary: Vaccines have relieved the public health burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and globally inactivated vaccines are most widely used. However, poor vaccination accessibility and waning immunity maintain the
Externí odkaz:
https://doaj.org/article/5be313e70944483e85a0601f5bf5dfe3
Autor:
Karen Anbro Gammeltoft, Yuyong Zhou, Line Abildgaard Ryberg, Long V. Pham, Alekxander Binderup, Carlos Rene Duarte Hernandez, Anna Offersgaard, Ulrik Fahnøe, Günther Herbert Johannes Peters, Santseharay Ramirez, Jens Bukh, Judith Margarete Gottwein
Publikováno v:
Viruses, Vol 15, Iss 9, p 1970 (2023)
Nirmatrelvir, which targets the SARS-CoV-2 main protease (Mpro), is the first-in-line drug for prevention and treatment of severe COVID-19, and additional Mpro inhibitors are in development. However, the risk of resistance development threatens the f
Externí odkaz:
https://doaj.org/article/68742ea5f82c460db78afaf14d9d85da
Autor:
Yuyong Zhou, Kerry Gilmore, Santseharay Ramirez, Eva Settels, Karen A. Gammeltoft, Long V. Pham, Ulrik Fahnøe, Shan Feng, Anna Offersgaard, Jakob Trimpert, Jens Bukh, Klaus Osterrieder, Judith M. Gottwein, Peter H. Seeberger
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Effective and affordable treatments for patients suffering from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are needed. We report in vitro efficacy of Artemisia annua extracts
Externí odkaz:
https://doaj.org/article/cb60e70748c8410cbc59a6f8b48eb14d
Autor:
Long V. Pham, Rodrigo Velázquez-Moctezuma, Ulrik Fahnøe, Laura Collignon, Priyanka Bajpai, Christina Sølund, Nina Weis, Kenn Holmbeck, Jannick Prentoe, Jens Bukh
Publikováno v:
Viruses, Vol 14, Iss 11, p 2527 (2022)
Hepatitis C virus (HCV) genotype 4 is highly prevalent in the Middle East and parts of Africa. Subtype 4d has recently spread among high-risk groups in Europe. However, 4d infectious culture systems are not available, hampering studies of drugs, as w
Externí odkaz:
https://doaj.org/article/a1d9cda048864f47943b04977b05abfb
Autor:
Alexander P. Underwood, Christina Sølund, Carlota Fernandez-Antunez, Signe Lysemose Villadsen, Anni Assing Winckelmann, Signe Bollerup, Lotte S. Mikkelsen, Anna-Louise Sørensen, Shan Feng, Ulrik Fahnøe, Ria Lassauniere, Anders Fomsgaard, Santseharay Ramirez, Nina Weis, Jens Bukh
Publikováno v:
EBioMedicine, Vol 71, Iss , Pp 103519- (2021)
Background: Given the importance of neutralising antibodies in protection against SARS-CoV-2 infection, it is critical to assess neutralisation persistence long-term following recovery. This study investigated neutralisation titres against SARS-CoV-2
Externí odkaz:
https://doaj.org/article/23070540111140e0a1440ec08ecbef27